<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: hiv drugs</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Computer models predict how patients will respond to HIV drugs</title>
   	 <description>Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucially for patients in poorer countries, the models do not require the results of expensive drug resistance tests to make their predictions. The study also showed that the models were able to identify alternative drug combinations that were predicted to work in cases where the treatment used in the clinic had failed, suggesting that their use could avoid treatment failure.</description>
     <link>http://medicalxpress.com/news/2013-03-patients-hiv-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 13 Mar 2013 20:10:01 EST</pubDate>
	 <guid isPermaLink="false">news282421952</guid>
	 
</item>
<item>
     <title>Nanoparticles loaded with bee venom kill HIV</title>
   	 <description>(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS.</description>
     <link>http://medicalxpress.com/news/2013-03-nanoparticles-bee-venom-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 08 Mar 2013 08:20:29 EST</pubDate>
	 <guid isPermaLink="false">news281953153</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/4-nanoparticle.jpg" width="90" height="90" />
</item>
<item>
     <title>American Academy of Microbiology releases resistance report</title>
   	 <description>What do cancer cells, weeds, and pathogens have in common? They all evolve resistance to the treatments that are supposed to eliminate them. However, researchers developing the next generation of antibiotics, herbicides, and anti-cancer therapeutics rarely come together to explore the common evolutionary principles at work across their different biological systems.</description>
     <link>http://medicalxpress.com/news/2013-03-american-academy-microbiology-resistance.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 07 Mar 2013 10:24:36 EST</pubDate>
	 <guid isPermaLink="false">news281874267</guid>
	 
</item>
<item>
     <title>US baby 'cured' of HIV: The experts respond</title>
   	 <description>US doctors have reported that, for the first time ever, a baby has been cured of HIV following drug treatment within hours of her birth.</description>
     <link>http://medicalxpress.com/news/2013-03-baby-hiv-expertsrespond.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 04 Mar 2013 07:53:37 EST</pubDate>
	 <guid isPermaLink="false">news281606002</guid>
	 
</item>
<item>
     <title>Researchers make HIV wake up call</title>
   	 <description>Researchers have moved a step closer to finding a cure for HIV by successfully luring the 'sleeping' virus out of hiding in infected cells.</description>
     <link>http://medicalxpress.com/news/2013-03-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 04 Mar 2013 07:50:01 EST</pubDate>
	 <guid isPermaLink="false">news281604450</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/melbourneres.jpg" width="90" height="90" />
</item>
<item>
     <title>Study finds 'Achilles heel' of key HIV replication protein</title>
   	 <description>Researchers at the University of Pittsburgh School of Medicine may have found an &quot;Achilles heel&quot; in a key HIV protein. In findings published online today in Chemistry and Biology, they showed that targeting this vulnerable spot could stop the virus from replicating, potentially thwarting HIV infection from progressing to full-blown AIDS.</description>
     <link>http://medicalxpress.com/news/2013-01-achilles-heel-key-hiv-replication.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 24 Jan 2013 12:00:09 EST</pubDate>
	 <guid isPermaLink="false">news278249573</guid>
	 
</item>
<item>
     <title>Antiretroviral treatment for HIV reduces food insecurity</title>
   	 <description>Can treatment with modern anti-HIV drugs help fight hunger for HIV-infected patients in Africa? Starting antiretroviral therapy for HIV reduces &quot;food insecurity&quot; among patients in Uganda, suggests a study published online by the journal AIDS, official journal of the International AIDS Society.</description>
     <link>http://medicalxpress.com/news/2012-12-antiretroviral-treatment-hiv-food-insecurity.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 04 Dec 2012 16:32:24 EST</pubDate>
	 <guid isPermaLink="false">news273861135</guid>
	 
</item>
<item>
     <title>Cancer drug shows promise in eradicating latent HIV infection</title>
   	 <description>Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more work must be done to actually cure the disease. One of the challenges researchers face involves fully eradicating the virus when it is latent in the body. A new report appearing in the December 2012 issue of the Journal of Leukocyte Biology suggests that a cancer drug, called JQ1, may be useful in purging latent HIV infection by activating the virus in the presence of potent therapy – essentially a dead end for the virus.</description>
     <link>http://medicalxpress.com/news/2012-11-cancer-drug-eradicating-latent-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 29 Nov 2012 11:32:17 EST</pubDate>
	 <guid isPermaLink="false">news273411124</guid>
	 
</item>
<item>
     <title>HIV treatment reduces risk of malaria recurrence in children, study shows</title>
   	 <description>A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.</description>
     <link>http://medicalxpress.com/news/2012-11-hiv-treatment-malaria-recurrence-children.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 28 Nov 2012 17:00:10 EST</pubDate>
	 <guid isPermaLink="false">news273344123</guid>
	 
</item>
<item>
     <title>Fifth of US youth with HIV unaware during first-time sex</title>
   	 <description>Twenty percent of young people born with HIV in the United States don't know they're infected when they have sex for the first time, according to a new study released Friday.</description>
     <link>http://medicalxpress.com/news/2012-11-youth-hiv-unaware-first-time-sex.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Sat, 10 Nov 2012 05:50:28 EST</pubDate>
	 <guid isPermaLink="false">news271749017</guid>
	 
</item>
<item>
     <title>Increased mortality in HIV-positive South African men versus women is unrelated to HIV/AIDS</title>
   	 <description>In South Africa, HIV-infected men who are receiving treatment with anti-HIV drugs (antiretroviral therapy) are almost a third more likely to die than HIV-positive women who are receiving similar treatment: however, these differences are likely to be due to gender differences in death rates in the general population rather than related to HIV, according to a study by a team of international researchers published in this week's PLOS Medicine.</description>
     <link>http://medicalxpress.com/news/2012-09-mortality-hiv-positive-south-african-men.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 04 Sep 2012 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news265972579</guid>
	 
</item>
<item>
     <title>US approves new once-a-day pill to treat HIV (Update)</title>
   	 <description> A new pill to treat HIV infection—combining two previously approved drugs plus two new ones—has been approved for adults living with the virus that causes AIDS, US regulators said Monday.</description>
     <link>http://medicalxpress.com/news/2012-08-fda-in-hiv-combination-pill.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 27 Aug 2012 17:58:59 EST</pubDate>
	 <guid isPermaLink="false">news265309134</guid>
	 
</item>
<item>
     <title>HIV drug may slow down metastatic breast cancer</title>
   	 <description>The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-06-hiv-drug-metastatic-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 06 Jun 2012 15:27:01 EST</pubDate>
	 <guid isPermaLink="false">news258215206</guid>
	 
</item>
<item>
     <title>Anti-HIV drug tenofovir is safe to take during pregnancy</title>
   	 <description>Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the use of this drug during pregnancy, according to a study by a team of international researchers published in this week's PLoS Medicine.</description>
     <link>http://medicalxpress.com/news/2012-05-anti-hiv-drug-tenofovir-safe-pregnancy.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 15 May 2012 17:00:11 EST</pubDate>
	 <guid isPermaLink="false">news256312370</guid>
	 
</item>
<item>
     <title>FDA panel backs first pill to block HIV infection</title>
   	 <description>The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.</description>
     <link>http://medicalxpress.com/news/2012-05-fda-panel-pill-block-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 11 May 2012 04:35:14 EST</pubDate>
	 <guid isPermaLink="false">news255929707</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelback.jpg" width="90" height="90" />
</item>
<item>
     <title>Pill to block HIV slated for testing</title>
   	 <description>California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.</description>
     <link>http://medicalxpress.com/news/2012-04-pill-block-hiv-slated.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 23 Apr 2012 05:30:23 EST</pubDate>
	 <guid isPermaLink="false">news254377815</guid>
	 
</item>
<item>
     <title>Sanofi teams up with India to make cheap ARVs in S.Africa</title>
   	 <description> French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.</description>
     <link>http://medicalxpress.com/news/2012-03-sanofi-teams-india-cheap-arvs.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 30 Mar 2012 13:16:27 EST</pubDate>
	 <guid isPermaLink="false">news252332179</guid>
	 
</item>
<item>
     <title>Study finds HIV-infected men at risk for spreading HIV despite taking HAART</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men who have sex with men (MSM). The findings, which currently appear on-line in AIDS, could indicate a potential transmission risk in MSM, who are highly susceptible to HIV infection.</description>
     <link>http://medicalxpress.com/news/2012-03-hiv-infected-men-hiv-haart.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 27 Mar 2012 10:46:52 EST</pubDate>
	 <guid isPermaLink="false">news252064004</guid>
	 
</item>
<item>
     <title>Bevacizumab active in HIV-linked Kaposi's sarcoma</title>
   	 <description>(HealthDay) -- For patients with HIV-associated Kaposi's sarcoma (HIV-KS), bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-03-bevacizumab-hiv-linked-kaposi-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 20 Mar 2012 10:19:27 EST</pubDate>
	 <guid isPermaLink="false">news251457546</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/bevacizumaba.jpg" width="90" height="90" />
</item>
<item>
     <title>American Heart Association comment: FDA announces safety changes on labeling for some statins</title>
   	 <description>The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).</description>
     <link>http://medicalxpress.com/news/2012-02-american-heart-association-comment-fda.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 29 Feb 2012 09:11:08 EST</pubDate>
	 <guid isPermaLink="false">news249729060</guid>
	 
</item>
<item>
     <title>Larger belly linked to memory problems in people with HIV</title>
   	 <description>A larger waistline may be linked to an increased risk of decreased mental functioning in people infected with the AIDS virus HIV, according to research published in the February 14, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-02-larger-belly-linked-memory-problems.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 13 Feb 2012 10:38:25 EST</pubDate>
	 <guid isPermaLink="false">news248351892</guid>
	 
</item>
<item>
     <title>How can pediatric HIV be eliminated in Zimbabwe?</title>
   	 <description>Eliminating new infant HIV infections in Zimbabwe will require not only improved access to antiretroviral medications but also support to help HIV-infected mothers continue taking their medication and safely reduce or eliminate breastfeeding, according to an article in the January issue of PLoS Medicine. Findings of the report from an international research team should help with the planning of expanded programs to prevent mother-to-child HIV transmission in sub-Saharan Africa and other areas with limited health resources.</description>
     <link>http://medicalxpress.com/news/2012-01-pediatric-hiv-zimbabwe.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 10 Jan 2012 17:41:50 EST</pubDate>
	 <guid isPermaLink="false">news245439703</guid>
	 
</item>
<item>
     <title>Guidelines stress caution when combining anti-epileptic, HIV drugs</title>
   	 <description>New guidelines from the American Academy of Neurology will help physicians better choose seizure drugs for people on HIV/AIDS medication, avoiding deadly drug interactions and preventing critical anti-HIV drugs from becoming less effective, possibly leading to a more virulent strain of the disease.</description>
     <link>http://medicalxpress.com/news/2012-01-guidelines-stress-caution-combining-anti-epileptic.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 04 Jan 2012 16:02:27 EST</pubDate>
	 <guid isPermaLink="false">news244915279</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/guidelinesst.jpg" width="90" height="90" />
</item>
<item>
     <title>Kenya HIV families torn between health or food</title>
   	 <description>(AP) --  Rosalia Adhiambo won't take the free anti-HIV drugs that would prolong her life. The spiraling price of food in Kenya means she can't afford to feed both her grandniece and herself.</description>
     <link>http://medicalxpress.com/news/2011-12-kenya-hiv-families-torn-health.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 22 Dec 2011 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news243765582</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/kenyahivfami.jpg" width="90" height="90" />
</item>
<item>
     <title>Cholesterol levels elevated in toddlers taking anti-HIV drugs</title>
   	 <description>(Medical Xpress) -- Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions.</description>
     <link>http://medicalxpress.com/news/2011-11-cholesterol-elevated-toddlers-anti-hiv-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 22 Nov 2011 09:37:31 EST</pubDate>
	 <guid isPermaLink="false">news241177037</guid>
	 
</item>
<item>
     <title>Could engineered fatty particles help prevent AIDS?</title>
   	 <description>Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries</description>
     <link>http://medicalxpress.com/news/2011-09-fatty-particles-aids.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 19 Sep 2011 16:48:44 EST</pubDate>
	 <guid isPermaLink="false">news235669669</guid>
	 
</item>
<item>
     <title>HIV prevention: Drugs even more effective than thought</title>
   	 <description> Using HIV treatment drugs to reduce the risk of spreading the AIDS virus may be even more effective than thought, according to new analysis from a landmark trial presented here on Monday.</description>
     <link>http://medicalxpress.com/news/2011-07-hiv-drugs-effective-thought.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 18 Jul 2011 11:23:38 EST</pubDate>
	 <guid isPermaLink="false">news230207007</guid>
	 
</item>
<item>
     <title>Drug designer: New tool reveals mutations that cause HIV-drug resistance</title>
   	 <description>Protease inhibitor drugs are one of the major weapons in the fight against HIV, the virus that causes AIDS, but their effectiveness is limited as the virus mutates and develops resistance to the drugs over time. Now a new tool has been developed to help predict the location of the mutations that lead to drug resistance.</description>
     <link>http://medicalxpress.com/news/2011-07-drug-tool-reveals-mutations-hiv-drug.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 08 Jul 2011 14:10:13 EST</pubDate>
	 <guid isPermaLink="false">news229352991</guid>
	 
</item>
<item>
     <title>Targeting tropical parasites</title>
   	 <description>Drugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from the University.</description>
     <link>http://medicalxpress.com/news/2011-05-tropical-parasites.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 11 May 2011 09:29:57 EST</pubDate>
	 <guid isPermaLink="false">news224324948</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/targetingtro.jpg" width="90" height="90" />
</item>


</channel>
</rss>
